Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ONEM | Common Stock | Options Exercise | +3.3K | +7.76% | 45.8K | Sep 1, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ONEM | Restricted Stock Units | Options Exercise | $0 | -3.3K | -33.33% | $0.00 | 6.6K | Sep 1, 2022 | Common Stock | 3.3K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis. |
F2 | Includes 98 shares that were issued to the reporting person in exchange for shares of common stock of Iora Health, Inc. ("Iora") upon the effective time of the merger between the issuer and Iora and pursuant to an exchange ratio set forth in the related merger agreement dated June 6, 2021. These 98 shares were inadvertently excluded from the Form 3 filed by the reporting person on September 3, 2021, as the shares were then being held in escrow pursuant to the merger agreement. |
F3 | On September 1, 2021, the reporting person was granted 9,903 restricted stock units, which vest in three equal installments, beginning on the first anniversary of the grant date. |